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Abstract
Liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC) are commonly induced by chronic hepatitis C virus (HCV)
infection. We aimed to identify and characterize the involvement of previously screened cytokine GDF15 in HCV
pathogenesis. We examined the GDF15 expression after HCV infection both in vitro and in vivo. Cultured JFH-1 HCV was
used to determine the GDF15 function on virus propagation. GDF15 overexpression and RNA interference were employed
to profile the GDF15-regulated genes, signaling pathways and cell biology phenotypes. The mRNA expression and protein
secretion of GDF15 was dramatically increased in HCV-infected hepatoma cells, which maybe a host response to viral
proteins or infection-induced cell stress. Patients infected with HCV had an average 15-fold higher blood GDF15 level than
that of healthy volunteers. Three HCC individuals in the HCV cohort showed extremely high GDF15 concentrations.
Transfection or exogenously supplied GDF15 enhanced HCV propagation, whereas knockdown of endogenous GDF15
resulted in inhibition of virus replication. Overexpressed GDF15 led to Akt activation and the phosphorylation of Akt
downstream targeted GSK-3b and Raf. Several HCC-related molecules, such as E-cadherin, b-catenin, Cyclin A2/B1/D1, were
up-regulated by GDF15 stimulation in vitro. Overexpression of GDF15 in hepatoma cells resulted in increased DNA synthesis,
promoted cell proliferation, and importantly enhanced invasiveness of the cells. In conclusion, these results suggest that an
elevated serum GDF15 level is a potential diagnostic marker for viral hepatitis, and GDF15 may contribute to HCV
pathogenesis by altering the signaling and growth of host cells.
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Introduction
Hepatitis C virus (HCV) is an important human pathogen
affecting an estimated 170 million people worldwide [1]. There is
no HCV vaccine available, and the existing pegylated interferon/
ribavirin standard-of-care antiviral therapy is only about 50%
effective in genotype 1 HCV and poorly tolerated. Chronic HCV
infection is often clinically asymptomatic but can frequently
progress to liver fibrosis, cirrhosis and hepatocellular carcinomas
(HCC). Although both viral proteins and dysregulated immuno-
cytes have been implicated for causing liver diseases, the
knowledge about HCV infection induced hepatopathogenesis is
still limited. Therefore, non-invasive serum predictors of HCV
infection and knowledge of their potential roles during disease
progression are urgently needed to help adjust treatment regimens
and understand pathogenic mechanisms.
Our previous work screened the possible involvement of growth
differentiation factor 15 (GDF15) during HCV infection [2].
GDF15, also known as macrophage inhibitory cytokine 1, is a
member of the transforming growth factor beta (TGF-b) cytokine
superfamily. GDF15 was first cloned from human monocytoid cell
line U937 and identified for inhibiting TNF-a production by
macrophages [3]. As a circulating cytokine, the function of GDF15
may be systemic and complicated. Recent studies suggest that
GDF15 might be involved in cell survival [4], cancer cell
invasiveness [5], tumor-induced anorexia and weight loss [6].
Association studies suggest that GDF15 is dramatically induced in
liver injury [7], cancers [8–10], cardiovascular diseases [11–13],
thalassemia [14] and HPV-mediated cervical cancer [15].
However, an association between GDF15 and viral hepatitis has
not been reported, so far.
In the present study, we identified the up-regulation of GDF15
in HCV-infected hepatoma cells and evaluated serum levels of
GDF15 in cohorts of patients with chronic hepatitis C or hepatitis
B. Additionally, we investigated the biological impact of increased
GDF15 on hepatoma cells. We demonstrate that GDF15 is an
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HCV (HBV) induced host circulating biomarker and may play
important roles during liver pathogenesis by regulating specific
pathways and HCC-related genes.
Results
HCV induces GDF15 expression in cultured hepatoma
cells
Our previous study revealed several HCV regulated serum
factors, in which GDF15 was constantly and dramatically induced
by HCVcc infection [2]. With microarray analysis, GDF15
mRNA showed a 10-fold to 16-fold increase in HCVcc-infected
Huh7.5.1 cells (Fig. 1A). Figure 1B showed the confirmation of
GDF15 induction using qRT-PCR, which has a much broader
dynamic and linear range compared with microarray. ELISA
results showed that the supernatant concentration of GDF15
protein was 0.59160.036 ng/mL in control cells and
1.17560.103 ng/mL in HCV-infected cells (Fig. 1C). Further-
more, in order to elucidate which viral protein may be causing this
upregulation, the selected individual HCV proteins were tran-
siently transfected into Huh7.5.1 cells, and the secreted GDF15
protein was determined by ELISA. The results shown in Fig. 1D
and 1E demonstrated that the expression of HCV structural
proteins (Core, E1 or E2), but not non-structure proteins (P7, NS2,
NS3, NS4A or NS5B), significantly induced GDF15 expression.
GDF15 concentration in human blood is elevated in HCV-
and HBV-infected patients
An increased plasma level of GDF15 has been documented in
several human diseases [11,14]. To understand the possible
correlation between the GDF15 level and hepatitis C in a clinical
setting, sera from healthy volunteers and treatment naı¨ve HCV-
Figure 1. HCV infection up-regulates GDF15 expression in vitro. Huh7.5.1 cells were infected with JFH-1 HCVcc (HCV, MOI = 1) or the same
amount of UV-inactivated virus (HCVUV) for 2 to 4 days (2–4 D). Total RNA was isolated for microarray and quantitative real-time RT-PCR analysis. (A)
GDF15 mRNA expression abundances were extracted from microarray raw data[2] and represented as fold increases. (B) GDF15 mRNA levels were
determined by real-time RT-PCR in the same manner as experiments designed in microarray analysis. (C) Concentrations of GDF15 protein in the
medium supernatants sampled on cultured Huh7.5.1 cells 3 days post HCV or HCVUV infection. (D) Huh7.5.1 cells seeded in a 24-well plate were
transfected with 1.5 mg of plasmid DNA, expressing the indicated viral proteins or an empty vector alone as a control. Three days after transfection,
the levels of secreted GDF15 in culture supernatants were quantified by the ELISA method. (E) By immunobloting, the successful expression of above
Flag-tagged individual viral proteins was confirmed. The position of each protein was indicated with a star sign.
doi:10.1371/journal.pone.0019967.g001
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infected patients were isolated for a GDF15 concentration
measurement. Meanwhile, the HBV-infected cohort was also
included as a control. Our major judgment for grouping was the
presence of viral nucleic acids and antibodies. The basic
characteristics of participants are summarized in Table 1.
Determined with a commercial ELISA kit, the concentration of
GDF15 in the healthy group ranged from 0.12 to 0.69 ng/mL,
with a median of 0.30 ng/mL. However, the GDF15 level was
significantly elevated in the HCV group (range 0.07–37.88 ng/
mL, mean = 4.62 ng/mL) and the HBV group (range 0.07–
6.31 ng/mL, mean = 1.39 ng/mL) (Fig. 2). The results from this
in vivo study were consistent with those of the in vitro HCV-induced
GDF15 up-regulation shown in Fig. 1. To further demonstrate the
possible association of disease with the GDF15 level, more detailed
characteristics about HCV participants are summarized in Table
S1. HCV viral loads were not linearly correlated to the level of
GDF15 expression. However, extremely high GDF15 levels were
observed in three patients with HCC (13.83, 35.18 and 37.21 ng/
mL respectively, indicated with an asterisk in Table S1).
GDF15 positively regulates HCV infection
To determine how GDF15 affects HCV propagation in
hepatocytes, gain-of-function and loss-of-function approaches
were employed. We developed Huh7.5.1 cells that stably
overexpress human GDF15 and an empty vector as control, using
retroviral-mediated gene transfer technology. Compared with
control Huh7.5.1 cells, the cells stably overexpressing GDF15
revealed an over 30-fold higher viral RNA copy number after
JFH-1 HCVcc infection (Fig. 3A). The overexpression of
intracellular GDF15 and secreted GDF15 in above stably
transfected Huh7.5.1 cells were confirmed by immunoblotting
and ELISA respectively (Fig. 3B and 3C). Similarly, the exogenous
GDF15 from both purified recombinant protein and stably
transfected Huh7.5.1 cell culture supernatant was able to increase
HCVcc propagation (Fig. 3D). Furthermore, because no pharma-
cological or chemical GDF15 inhibitors were reported, the
endogenous GDF15 expression was knocked down with shRNAi
in HCVcc-infected Huh7.5.1 cells. Compared with the empty
vector control and non-specific shRNAi, HCV replication was
significantly suppressed after down-regulation of GDF15 expres-
sion (Fig. 3E). Together, these results demonstrated that GDF15,
as an HCV-induced cytokine, could positively regulate JFH-1
HCV infection in cell culture system.
Akt signaling pathway is regulated by GDF15 in
hepatoma cells
To investigate the possible significance of HCV-induced GDF15
up-regulation on host response, several intracellular signaling
pathways were measured in Huh7.5.1 cells stably overexpressing
human GDF15. As a TGF-b superfamily member, GDF15 most
likely uses the Smad pathway. However, the phosphorylation status
of Smad1, 2 and 5 remained unchanged by GDF15 (Fig. 4). The
total protein and phosphorylated-Smad3 levels were below the
detection limitation in the cells we used (data not shown). The steady
levels of inhibitory Smad (Smad7) and Co-Smad (Smad4) were not
influenced by GDF15 (data not shown). However, Akt at Ser473
was significantly phophorylated by GDF15 (Fig. 4). Accordingly,
two downstream targets of Akt, c-Raf (Ser259) and GSK-3b (Ser9),
were also phosphorylated by GDF15 (Fig. 4). The activity of
intracellular mitogen-activated protein kinases, including Erk1/2
and p38, was not altered by GDF15 in the current experimental
system (data not shown). These results suggest that the Akt pathway
might play a critical role in mediating GDF15-regulated physio-
logical effects in hepatoma cells in vitro.
Gene array analysis reveals the regulation of HCC-related
genes by GDF15
To systematically profile the GDF15-regulated genes in hepato-
ma cells and to elucidate the possible role of GDF15 on biological
processes, high-density oligonucleotide microarrays were hybridized
with samples prepared from GDF15- or PBS-treated Huh7.5.1 cells.
We found that a total of 894 genes were differentially expressed in
response to GDF15 treatment based on the 2-fold cut-off range, and
a majority (828 genes, about 92.6%) of the genes is up-regulated
(Fig. 5A). According to the descriptions outlined by the Gene
Ontology Biological Process, the differentially expressed genes were
found to belong to a variety of functional categories (Fig. 5B, 5C).
We assessed the expression of a set of genes that were previously
reported by several groups with their potential involvement in HCC
and summarized the results in Table 2. These HCC-associated
genes include AFP, b-catenin, cyclin B1, c-myc, FOXO1A,
IFNAR1, SOCS2, EGF, E-cadherin, CDKN2A, and IGFBP3
etc. Interestingly, more than half of the selected genes showed
alterations in their expression. These results suggest that as an
upstream regulator, excess GDF15 can sufficiently change the
expression homeostasis of the HCC-associated gene setting.
Table 1. Basic Information about the Study Population.
Healthy HCV HBV
Total n = 53 n = 54 n = 56
Age, years 41 (21–69) 48 (20–70) 41 (18–76)
Sex male, % n = 29, 54.7% n = 30, 55.6% n = 45, 80.4%
doi:10.1371/journal.pone.0019967.t001
Figure 2. Blood GDF15 concentration is increased in HCV- or
HBV-infected subjects. GDF15 concentrations in blood from healthy
volunteers (n = 53) and patients with chronic hepatitis C (HCV, n = 54) or
hepatitis B (HBV, n = 56) were analyzed by ELISA, and the results are
depicted as box (25th percentile and 75th percentile) and whisker (5th
and 95th percentiles) plots. The median was indicated as an open star.
Data scatter plots are also demonstrated.
doi:10.1371/journal.pone.0019967.g002
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GDF15 modulates the cell cycle, proliferation and
invasiveness of hepatoma cells
To investigate the possible effect of GDF15 on cell biological
characteristics, we engineered Huh7.5.1 cells that stably overex-
press GDF15 or an empty vector as control. With flow cytometry
analysis of DNA content, we observed that the percent of cells
present in DNA synthesis phase of the cell cycle was increased by
GDF15 overexpression (Fig. 6A). Meanwhile, GDF15 showed an
enhancement of hepatoma cell proliferation (Fig. 6B). Using a
similar experimental design, we further observed that overexpres-
Figure 3. GDF15 positively regulates HCV infection. (A) Naı¨ve Huh7.5.1 cells stably expressing human GDF15 or an empty vector as control
(Ctrl) were cultured in 24-well plates and infected with JFH-1 HCVcc (MOI = 1) respectively. Forty eight hours post virus infection, total cellular RNA
was isolated for HCV genomic RNA quantification using real-time RT-PCR. (B) The above cells were lysed for the detection of Flag-tagged GDF15
expression by immunobloting with the anti-Flag antibody (M2). Beta-Actin served as the sample equal loading control. (C) Besides the confirmation
of the intracellular overexpression of transfected GDF15, the cell culture supernatants were collected from naı¨ve Huh7.5.1 cells stably expressing
human GDF15 or an empty vector for determination of the secreted GDF15 by ELISA. (D) Naı¨ve Huh7.5.1 cells were treated with exogenous
recombinant GDF15 protein (3 ng/mL) or conditioned media from GDF15 transfected Huh7.5.1 cell culture supernatant for 12 hours before JFH-1
HCVcc infection (MOI = 1). Forty eight hours post virus infection, total cellular RNA was isolated for HCV genomic RNA quantification using real-time
RT-PCR. (E) Knockdown of GDF15 inhibits HCV replication. Naive Huh7.5.1 cells were transduced with shRNAi lentiviral particles of targeting GDF15
(GDF15#1 and #2), empty vector (control) and non-specific targeting, and then infected with JFH-1 HCVcc (MOI = 1) for 2 days. GDF15 mRNA and
HCV viral RNA was quantified by real-time RT-PCR and plotted as fold changes. All experiments were conduct in triplicate, and error bars represent
standard deviations.
doi:10.1371/journal.pone.0019967.g003
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sion of GDF15 promoted the invasiveness of Huh7.5.1 cells
(Fig. 6C&D). These results suggest that GDF15 regulates multiple
cell growth related phenotypes.
Discussion
Different mechanisms have been proposed to explain HCV
pathogenesis, including fibrogenesis and HCC. Among these
mechanisms, an involvement of the virus-host interactions has
been suggested by a number of in vitro and in vivo studies. The
identification of HCV infection-regulated host serum factors
allows us to explore predictive biomarkers, and to mechanistically
investigate the host response upon infection. In this study, we have
shown that the HCV infection is characterized by higher-than-
normal GDF15 levels, and elevated GDF15 potentially regulates
both HCV replication and host HCC-related signaling pathway
and genes.
The TGF-b superfamily of ligands plays a pivotal role in the
regulation of a wide variety of physiological processes from
development to pathogenesis. GDF15 was originally discovered as
a factor in immune regulation [3] and was subsequently
considered a host responsive factor linked to tissue injury [7],
cardiovascular events [11–13] and cancers [8,9]. However, the
correlations between the GDF15 expression level and virus
infections (especially for hepatitis viruses) are undefined. We
observed that 37 of 54 (68.5%) HCV and 50 of 56 (89.3%) HBV
patients had a GDF15 level higher than the average GDF15 level
in the healthy volunteers in the control group. Notably, the
induction of GDF15 in both HCV and HBV infected patients
suggests that GDF15 probably is a non-specific liver injury
responsive cytokine in viral hepatitis and other hepatic diseases. As
a circulating cytokine, GDF15 may function by transducing signals
to target cells through the autocrine, paracrine and endocrine
systems. So far, a variety of GDF15 biological functions has been
reported, such as an anti-apoptotic in cardiomyocytes [16],
metastasis in prostate cancer cells [17], motoneuron development
[18], osteoclast differentiation [19], iron overloading and eryth-
ropoiesis [14,20]. Therefore, it is possible that HCV infection
might exert a systemic influence on extrahepatic manifestations
during disease using GDF15 as a communicator.
Previous studies reported that the TGF-b1 level was elevated in
chronic hepatitis C liver biopsy samples and urine [21,22], but the
association of the cytokine level and disease progression has not yet
been clearly concluded. In the HCV-infected patients, we tried to
assess the possible relationship between serum GDF15 levels and
several disease characteristics, including viral load, genotypes and
liver disease progression. Limited by the small number of subjects
in the cohorts, we did not observe an accurate correlation, with the
exception of 3 HCC patients that had extremely high levels of
circulating GDF15 (Table S1, indicated with asterisk). This result
suggests the possible involvement of GDF15 in HCV-related liver
carcinogenesis and needs to be further verified in an extensive
study with a large cohort. Several signal transduction cascades and
molecules have been implicated to be involved in hepatocarcin-
ogenesis [23,24], although the detailed regulatory mechanisms
remain to be elucidated. Our results demonstrated that Smad
signaling, the classical intracellular cascade used by TGF-b
superfamily members, was not activated by GDF15 in Huh7.5.1
cells. However, significant phosphorylation of Akt/GSK-3b was
detected upon GDF15 overexpression (Fig. 4). Akt, a serine/
threonine kinase, is responsible for regulation at multiple levels of
cell growth and apoptotic processes, as well as liver carcinoma
[25]. When the PI3K/Akt pathway is activated, GSK-3b, one of
the major downstream substrates of Akt, is phosphorylated and
then inhibited, which impairs the proteosome-dependent degra-
dation of targets molecules, such as cyclin D1 and b-catenin
[26,27]. Also, unconventional activation of Akt was observed in
HCC [28]. In addition, we identified a panel of important cancer-
related genes, which were differentially expressed upon GDF15
stimulation. These genes included oncogenes b-catenin, E-
cadherin, c-myc, cyclins, CDK2 and IGFBP3. A number of these
genes were reported to be dysregulated in HCC. Importantly, we
found that increased GDF15 regulated liver cell proliferation, cell
cycle progression, even cell invasiveness. These results suggest that
as an early and upstream response host factor of HCV infection,
GDF15 might play profound roles in multiple cellular events.
This study also, for the first time, offers evidence that increased
GDF15 expression promotes JFH-1 based HCVcc replication in
cultured hepatoma cells. Moreover, knockdown of GDF15 by
RNA interference suppresses HCV replication (Fig. 3). The
biological role of TGF-b in HCV replication was controversially
reported. A dose-dependent effect of TGF-b1 on the enhancement
of HCV replication was observed [29], whereas Murata and
colleagues reported the suppression of the HCV replicon by TGF-
b via cell growth arrest [30]. Results from this study suggest that
GDF15 up-regulation may be a host positive feedback mechanism
for HCV infection. The broad effects of GDF15 on immune and
transcription regulation might be involved in the modulation of
HCV replication. Hopefully, approaches that specifically target
GDF15 signaling will suppress HCV infection and the severity of
liver disease.
Taken together, these findings provide evidence that host GDF15
is produced and secreted at high levels during HCV infection, which
is probably caused by either viral agents or host stress/injury, or by
both. We demonstrated that GDF15 may be normally required for
efficient HCV infection and, as a homeostasis cytokine, may
systematically regulate HCC-related signal transduction pathways
and genes. Therefore, we propose that GDF15 represents a
potential biomarker and interventional target for hepatitis C or B.
A further large-scale association study is urgently needed for the
predictive significance of GDF15 in viral hepatitis.
Materials and Methods
Cells and reagents
The human hepatoma cell line Huh7.5.1 was provided by Dr.
Francis V. Chisari (The Scripps Research Institute, La Jolla, CA).
HEK293T cells were obtained from ATCC. All cell lines were
maintained in Dulbecco’s Modified Eagle Medium (Invitrogen,
Carlsbad, CA) supplemented with 1% penicillin and streptomycin
Figure 4. The Akt pathway is regulated by GDF15 overexpres-
sion in hepatoma cells. Huh7.5.1 cells stably expressing human
GDF15 or an empty vector as control were analyzed for multiple signal
cascades activation by immunobloting using the indicated antibodies.
doi:10.1371/journal.pone.0019967.g004
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(Gibco), 1% NEAA (Gibco), and 10% fetal bovine serum (Gibco)
in a 37uC 5% CO2 atmosphere. Recombinant human GDF15 was
obtained from R&D Systems (Minneapolis, MN). All antibodies
were obtained from Cell Signaling (Danvers, MA).
HCV cell culture viral infections and quantitative real time
RT-PCR (qRT-PCR)
The production of JFH-1 (genotype 2a) HCV cell culture virus
(HCVcc) was performed as previously described [2]. Inactivation
of HCVcc by UV was achieved by exposing virus-containing
supernatant in a Petri dish (0.5 cm depth) to a 254 nm UV source
at 1.8 Jm-2 per second for 30 minutes. This inactivated virus was
designated HCVUV. Infection of Huh7.5.1 cells, seeded in 24-well
plates the day before, was performed in 500 mL of medium
containing HCVcc (MOI = 0.5,1). After the infection was
allowed to proceed for 3 hours at 37uC, the unbound virus was
washed away with phosphate-buffered saline (PBS), and the
medium was replaced. At various time points (48, 72, or 96 hours)
post infection, the cells or culture media were collected for the
quantification of GDF15 or HCV. For the GDF15 treatment, the
Figure 5. Profiling of GDF15 regulated gene expression. (A) Overall differentially expressed genes in GDF15-treated Huh7.5.1 cells. (B) and (C)
demonstrate, respectively, the up-regulated and down-regulated genes that are grouped by the corresponding gene ontology biological process.
Interestingly, the majority of genes up-regulated by GDF15 are involved in cellular signal transduction and transcription regulation.
doi:10.1371/journal.pone.0019967.g005
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Table 2. Expression level of HCC-associated genes in GDF15-treated Huh7.5.1 cells.
Genes PBS treatment GDF15 treatment p Value Fold (GDF/PBS)
PCNA 3436.56341.5 18403.561221.2 0.00357 5.36
Cyclin A2 20356140.0 71476673.2 0.00892 3.51
IGFBP3 610663.6 19376233.3 0.01621 3.18
Cyclin B1 3188.56767.2 9498.56393.9 0.00921 2.98
CDK2 539.56113.8 15276113.1 0.01295 2.83
E-cadherin 1830.56495.7 5000.561085.4 0.06411 2.73
b-catenin 5582.56761.6 145966189.5 0.00377 2.61
c-myc 3978.56146.4 7181.56608.8 0.01858 1.81
Cyclin D1 45336233.3 7604.56518.3 0.01670 1.68
SOCS2 5965.7 7167.1 0.20177 1.20
TGF-a 249636.8 257641.0 0.85627 1.03
AFP 3624262907.6 36955.561689.3 0.79244 1.02
CDK4 10174.56253.9 103036264.5 0.66920 1.01
EGF 4776137.2 457.56108.2 0.88907 0.96
FOXO1A 10796364.9 10386422.8 0.92679 0.96
IFNAR1 310.566.4 286642.4 0.50409 0.92
CDKN2A 2896.56600.3 23756377.6 0.40759 0.82
doi:10.1371/journal.pone.0019967.t002
Figure 6. GDF15 regulates hepatoma cell cycle, proliferation and invasion. (A) Engineered Huh7.5.1 cells stably overexpressing GDF15 or
an integrated empty vector control were harvested at exponential growth stage and stained by PI for cell cycle distribution analysis. (B) 104 of above
two types of cells were seeded in 96-well plate for cell proliferation assay with a MTT method. (C) The transwell invasion assay was performed as
described in Materials and Methods using above GDF15 overexpressing and control cells. Magnification in the invasion assay is 2006. (D) The
normalized ratio of the in vitro invasion assay.
doi:10.1371/journal.pone.0019967.g006
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recombinant protein was added to Huh7.5.1 cells 24 hours prior
to microarray analysis. Quantification of HCV RNA was
performed by qRT-PCR, as previously described [31].
Patients and healthy volunteers
Serum samples were drawn from hospital patients diagnosed
with HCV or hepatitis B virus (HBV) infection. As a control,
healthy volunteers with comparable age and gender distribution to
the HCV- or HBV-infected patients were recruited from clinic
physical examinations. At the time of enrollment, the written
informed consent was obtained for the collection, storage of serum,
and the purpose of the study. The experimental design and
protocol were reviewed and approved by the ethics committee of
Institute of Pathogen Biology. The patients’ HCV or HBV status
was confirmed by the presence of detectable serum HCV-RNA or
HBV-DNA (Cobas Taqman test, Roche). Patients with a co-
infection of HCV and HBV were excluded from the cohorts.
Analysis of viral nucleic acids confirmed that healthy volunteers
were free of HCV and HBV. There were 54 HCV-infected and 56
HBV-infected subjects, who were all treatment naı¨ve. The
subjects’ serum and clinical data were extracted from medical
records and laboratory reports.
Measurement of GDF15 concentrations
The GDF15 protein levels in serum and cell culture
supernatants were determined using a sandwich ELISA kit
(R&D Systems), according to the manufacturer’s instructions.
The reaction was read under 450 nm with a SpectraMax M5
Multi-Mode Microplate Reader (Molecular Devices, Sunnyvale,
CA). Each sample was analyzed in triplicate for statistical analysis.
The GDF15 concentration of each sample was calculated using a
standard curve and the measured absorbance.
Plasmids construction, transfection and Immunoblotting
Plasmids encoding individual HCV proteins were constructed as
previously described [32]. Huh7.5.1 cells seeded in a 24-well plate
were transiently transfected with 1.5 mg of plasmid DNA plus 3 mL
of TransMax transfection reagent (Giantagen, Beijing, China).
Forty-eight hours post transfection, the cell culture supernatants
were clarified by centrifugation for the GDF15 ELISA. Human
GDF15 cDNA was cloned between the BamHI/XhoI sites of the
pMIR-cFlag plasmid for expression and to generate an C-terminal
Flag-tagged GDF15 fusion protein. To knockdown GDF15, two
short hairpin RNA vectors and a non-specific control vector were
constructed based on the pQSupR retroviral RNAi system, as
previously described [33]. The target sequences of shRNA are as
follows: GDF15#1 (59-AAC CTG CAC AGC CAT GCC CGG-
39), GDF15#2 (59-AAC TCA GGA CGG TGA ATG GCT-39),
and non-specific (59-AAC GAC CGA TCC GCA CCG GCT-39).
For intracellular signal transduction analysis, the Huh7.5.1 cells
stably transfected with empty vector or GDF15 expressing plasmid
were lysed and the immunoblotting procedure was performed
according to the previous reference[34] and antibody manufac-
ture’s instruction.
Microarrays analysis
Huh7.5.1 cells were treated with recombinant GDF15 (10 ng/
mL) or PBS for 24 hours. The microarray hybridization and
analysis were performed by CapitalBio Corporation (Beijing,
China) using the 22K Human Genome Array. Only genes that
were either induced or reduced more than 2-fold in any of the
samples were considered to be significantly up- or down-regulated
by GDF15. All data is MIAME (Minimum Information About a
Microarray Experiment) compliant and that the raw data has been
deposited in GEO with the accession number of GSE25397.
Cell cycle, proliferation and in vitro invasion assay
Huh7.5.1 cells, that stably overexpress GDF15 or an empty
vector as control, were stained with Propidium Iodide (PI) and
analyzed on a BD FACSCanto II flow cytometer for cell cycle
distribution. For cell proliferation assay, about 104 cells were
seeded in each well of 96-well plates and analyzed with a non-
radioactive/colorimetric method according to the manufacture’s
instructions (Promega). The in vitro invasion assay was performed
using a Matrigel-coated membrane matrix (BD Bioscience) in the
insert of a 24-well culture plate according to the manufacture’s
instructions. The assays were performed in three replicates and
repeated three times.
Statistical analysis
Two sample independent t-test statistics was employed to
evaluate differences in GDF15 levels in healthy, HCV and HBV
cohorts. Data are presented as a percentage, median (25th to 75th
percentiles), or mean (SD), as indicated.
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